Article
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
Cancer research - 1 Apr 2003
Kimura Edna T, Nikiforova Marina N, Zhu Zhaowen, Knauf Jeffrey A, Nikiforov Yuri E, Fagin James A
Abstract excerpt
Thyroid papillary cancers (PTCs) are associated with activating mutations of genes coding for RET or TRK tyrosine kinase receptors, as well as of RAS genes. Activating mutations of BRAF were reported recently in most melanomas and a small proportion of colorectal tumors. Here we show that a somatic mutation of BRAF, V599E, is the most common genetic change in PTCs (28 of 78; 35.8%). BRAF(V599E) mutations were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.